...
首页> 外文期刊>Polish Archives of Internal Medicine >Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)
【24h】

Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)

机译:口腔颤动患者的波兰和欧洲管理策略。来自欧元产病学研究方案颤动的数据通用登记处试验阶段(EORP-AF试点)

获取原文

摘要

INTRODUCTION Despite continued efforts of the European Society of Cardiology (ESC) to unify management of patients with atrial fibrillation (AF) across Europe, interregional differences in guideline adherence are likely. OBJECTIVES The aim of the study was to compare treatment strategies depending on baseline characteristics of AF patients between Poland and other members of the European Union (EU). PATIENTS AND METHODS We analyzed the baseline data and treatment strategies in participants of the ESC registry: the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. A total of 3119 consecutive patients with AF diagnosed within the last year were included in 67 centers from 9 countries, including 419 patients enrolled in 15 Polish centers. RESULTS A rhythm control strategy was more frequent in Poland than in other EU countries (20.8% vs 11.9%; P <0.0001). Catheter ablation for AF was also used more frequently in Polish cardiology wards (13.9% vs 8.3%; P = 0.0017), while amiodarone at discharge was used less frequently (12.0% vs 22.7%; P <0.0001). In-hospital use of vitamin K antagonists (VKAs) and non-VKA anticoagulants was less frequent in Polish patients with a CHA2DS2-VASc score of 2 or higher than in patients from other EU countries (61.1% vs 79.0%; P <0.0001), but overall anticoagulation rates at discharge were similar to those in other countries (83.3% vs 82.6%). CONCLUSIONS A rhythm control-oriented strategy in patients with AF with the use of ablation in cardiology wards is more frequent in Poland than in other EU countries. Similar to other EU countries, compliance with the ESC guidelines regarding anticoagulation in AF patients is suboptimal in Poland. Undertreatment was observed in a significant proportion of patients at high risk of stroke, while a large group of low-risk patients are overtreated. Differences between the types of recruiting centers in Poland and other EU countries might have influenced the results.
机译:尽管欧洲心脏病学会(ESC)持续努力,但统一对欧洲心房颤动(AF)的患者的管理,可能的指南依从性的区域间差异很可能。目标该研究的目的是根据波兰和其他欧盟(欧盟)的其他成员之间的AF患者的基线特征进行比较治疗策略。患者和方法我们分析了ESC登记处的参与者中的基线数据和治疗策略:Eurobserational Research计划心房颤动一般登记处试验阶段。共有3119名在去年内诊断的3119名患者被列入了9个国家的67个中心,其中包括419名波兰中心的患者。结果波兰的节奏控制策略比在其他欧盟国家(20.8%vs11.9%; P <0.0001),更频繁。在波兰心脏病病房中也更频繁地使用AF的导管消融(13.9%Vs 8.3%; P = 0.0017),而胺碘酮在放电时较少使用(12.0%Vs 22.7%; P <0.0001)。在医院使用维生素K拮抗剂(VKAS)和非VKA抗凝血剂在波兰患者中缺乏频繁的患者,其CHA2DS2-VASC评分为2或高于其他欧盟国家的患者(61.1%VS 79.0%; P <0.0001)但是,放电的整体抗凝率类似于其他国家(83.3%vs 82.6%)。结论AF患者的节奏控制导向策略在心脏病病房中使用消融患者比其他欧盟国家更频繁。与其他欧盟国家类似,遵守有关AF患者抗凝的ESC指南在波兰次优。在卒中风险高的患者中观察到底部,而大量的低风险患者过度治疗。波兰和其他欧盟国家的招聘中心类型之间的差异可能影响了结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号